About this trial
Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Olmsted County residents at the time of search
Age 18 or older
No personal history of NAFLD diagnosis (administrative codes)
Disqualifiers
Alcohol in excess (more than 20 gm per week in women and 30 gm per week in men)
Currently pregnant
Have contraindications to MRI (MRI incompatible implanted devices, severe claustrophobia)
Trial design
Single group
Treatments tested in this trial
Magnetic Resonance Elastography
Diagnostic testCombines MRI imaging with sound waves to create a visual map (elastogram) showing the stiffness of body tissues.
Blood draw
Other interventionClinical blood tests with a focus on liver function parameters and diabetes
Liver biopsy
Procedure/SurgeryIf indicated per MRE results a biopsy will be taken of the liver.
Fibro Scan
Procedure/SurgeryIf indicated per MRE results a fibroscan will be performed of the liver.
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of NAFLD and NASH in the population
Number of subjects with NAFLD and NASH determined by the MRE
Secondary outcomes
Long-term health outcomes
Number of participants to experience the development of NAFLD, NASH, NASH cirrhosis complications, liver transplant, cardiovascular events, cancers or death
Sponsors and contacts
Click on the lead sponsor to view all of their trials.